Critical analysis of common canister programs: a review of cross-functional considerations and health system economics

References

• Lamphere T. Common canister protocol: risk or reward? AARC Times 2009;46-9
   Google Scholar
• CDC/NCHS National Hospital Discharge Survey. Number, rate, and average length of stay for discharges from short-stay hospitals, by age, region, and sex: United States, 2010. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHDS/NHDS_2010_Documentation.pdf [Last accessed 9 2014]
   Google Scholar
• Neel S, Tauman A. Can successful implementation of the common canister program deliver cost containment and improved infection control? Hosp Pharm 2012;47:700-11
   Google Scholar
• Sakaan S, Finch C, Ulrich D, et al. Inhaler use in hospitalized COPD/asthma patients: assessment of wasted doses. American Thoracic Society International Conference, San Diego, 2014
   Google Scholar
• Cohen MR, Smetzer JL. Shared metered dose inhalers: is cross-contamination avoidable? Hosp Pharm 2009;44:546-8
   Google Scholar
• Ehlers K, Albritton SR, Stogner S. Common Canister Protocol Vs. Individually Supplied MDI’s at a 537 bed Regional Center – A Pharmacoeconomic Analysis. New Orleans: American Association for Respiratory Care, 2004
   Google Scholar
• Liou J, Clyne K, Knapp D, Snyder J. Establishing a quality control program: ensuring safety from contamination for recycled metered-dose inhalers. Hosp Pharm 2014;49:437-43
   PubMedGoogle Scholar
• Smith T. Inpatient inhaler program puts savings in the can. UCH Insider 2012;5:1-3
   Google Scholar
• Martin M, Winterfeld I, Kramme E, et al. [Outbreak of Burkholderia cepacia complex caused by contaminated alcohol-free mouthwash]. Der Anaesthesist 2012;61:25-9
   PubMed Web of Science ®Google Scholar
• Grissinger M. Shared metered dose inhalers among multiple patients: can cross-contamination be avoided? Pharm Therapeut 2013;38:434-42
   Google Scholar
• Hinson D, Rau JL. Incidence of contamination of metered dose inhaler canisters when used with multiple patients using spacer devices. Respir Care 1996 Open Forum Abstracts. Available at: http://www.rcjournal.com/abstracts/1996/?id=A00001206 [Last accessed 16 June 2014]
   Google Scholar
• Institute for Safe Medication Practices. Shared MDIs: can cross-contamination be avoided? ISMP Medication Safety Alert 2009;7:1-3
   Google Scholar
• Dunlevy CL, Rau JL, Roman SB. Surveillance of reservoir cross-contamination with multiple patient MDI use. Respir Care. 1997 Open Forum Abstracts. Available at: http://www.rcjournal.com/abstracts/1997/?id=A00001076 [Last accessed 15 June 2014]
   Google Scholar
• Sheils SG, Duncan JL, Wojciechowski WV. The common canister protocol using the Monaghan AeroChamber reveals no cross-contamination and potential cost savings. Respir Care 2000;45:981
   Google Scholar
• Wojciechowski WV, Maddox HC, Moseley AL. Analysis of cross-contamination of metered dose inhalers when using the Respironics Optichamber under the common canister protocol. Respir Care. 2001 Open Forum Abstracts. Available at: http://www.rcjournal.com/abstracts/2001/?id=A00000079 [Last accessed 19 June 2014]
   Google Scholar
• Mantz HD, Radke L, Gunn J. Open forum abstracts 2009: common canister process for delivering aerosol medications: the final steps to assure patient safety. Respir Care Website. Available at: http://www.rcjournal.com/abstracts/2009/?id5679698 [Last accessed 6 October 2014]
   Google Scholar
• Laher DS, Sandusky F, Schoolcraft L. Open forum abstracts 2008: infection control surveillance study of the common canister protocol. Respir Care Website. Available at: http://www.rcjournal.com/abstracts/2008/?id5aarc08_163 [Last accessed 6 October 2014]
   Google Scholar
• Livia M, Mirzoyan M, Taylor HC, et al. Bacteriologic assessment of reused metered dose inhalers: an analysis of the safety of the ‘common canister protocol’. Infect Dis Clin Pract 2011;19:265-67. Available at: http://journals.lww.com/infectdis/Abstract/publishahead/Bacteriologic_Assessment_of_Reused_Metered_Dose.99727.aspx [Last accessed 6 October 2014]
   Google Scholar
• Drug Information Group. University of Illinois at Chicago. College of Pharmacy. Available at: http://dig.pharm.uic.edu/faq/2012/Oct/faq1.aspx [Last accessed 9 July 2014]
   Google Scholar
• Common Canister Protocol for Inhaler Administration in Mechanically Ventilated Patients. NCT01935388. Available at: http://clinicaltrials.gov/show/NCT01935388 [Last accessed 9 July 2014]
   Google Scholar
• Tennessee Board of Respiratory Care. Position Statement Concurrent Therapy. Available at: http://health.state.tn.us/boards/RC/PDFs/RC_Concurrent_Therapy.pdf [Last accessed 24 September 2014]
   Google Scholar
• Reinarz JA, Pierce AK, Mays BB, Sanford JP. The potential role of inhalation therapy equipment in nosocomial pulmonary infection. J Clin Invest 1965;44:831-9
   PubMed Web of Science ®Google Scholar
• Pierce AK, Sanford JP, Thomas GD, Leonard JS. Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. New Engl J Med 1970;282:528-31
   PubMed Web of Science ®Google Scholar
• Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Amer J Infect Contr 2002;30:145-52
   PubMed Web of Science ®Google Scholar
• Perez-Ayala M, Oliver P, Rodriguez Cantalejo F. Prevalence of bacterial contamination of glucose test strips in individual single-use packets versus multiple-use vials. J Diab Sci Tech 2013;7:854-62
   PubMedGoogle Scholar
• World Health Organization. WHO Guidelines on Hand Hygiene in Health Care: a Summary. 2009. Available at: http://www.who.int/gpsc/5may/tools/who_guidelines-handhygiene_summary.pdf [Last accessed 9 July 2014]
   Google Scholar
• Smith SJ, Young V, Robertson C, Dancer SJ. Where do hands go? An audit of sequential hand-touch events on a hospital ward. J Hosp Infect 2012;80:206-11
   PubMed Web of Science ®Google Scholar
• Won SP, Chou HC, Hsieh WS, et al. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect Cont Hosp Epidem 2004;25:742-6
   PubMed Web of Science ®Google Scholar
• Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. New Engl J Med 2014;370:1198-208
   PubMed Web of Science ®Google Scholar
• Cohen HA, Cohen Z, Pomeranz AS, et al. Bacterial contamination of spacer devices used by asthmatic children. J Asthma 2005;42:169-72
   PubMed Web of Science ®Google Scholar
• de Vries TW, Rienstra SR, van der Vorm ER. Bacterial contamination of inhalation chambers: results of a pilot study. J Aerosol Med 2004;17:354-6
   PubMedGoogle Scholar
• de Vries TW, Rottier BL, Visserman H, et al. The influence of inhaled corticosteroids and spacer devices on the growth of respiratory pathogenic microorganisms. Amer J Infect Cont 2009;37:237-40
   PubMed Web of Science ®Google Scholar
• Saiman L, Siegel J, Cystic Fibrosis F. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Cont Hosp Epidem 2003;24(5 Suppl):S6-52
   PubMed Web of Science ®Google Scholar
• Aitken M, Bilton D, Piñero R, et al. Mannitol inhaler device culture: no evidence of an increased microbiological contamination. J Cystic Fibrosis 2011;1:10
   Google Scholar
• Harkins KJ. Bacterial contamination of inhalers. J Hosp Infect 1999;43:321
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR 1997;46:1-79
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Guidelines for preventing health-care associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR 2004;53:1-36
   PubMedGoogle Scholar
• Kleinpell RM, Munro CL, Guiliano KK. Chapter 42. Targeting health care–associated infections: evidence-based strategies. In: Hughes RG, ed. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Rockville, MD: Agency for Healthcare Research and Quality (US), 2008
   Google Scholar
• Chastre J, Fagon JY. Ventilator-associated pneumonia. Amer J Resp Crit Care Med 2002;165:867-903
   PubMed Web of Science ®Google Scholar
• Laessig KA. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective. Clin Infect Dis 2010;51(Suppl 1):S117-19
   PubMed Web of Science ®Google Scholar
• Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. 2009. Available at: http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf [Last accessed 17 June 2014]
   Google Scholar
• Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Int Med 2010;170:347-53
   PubMed Web of Science ®Google Scholar
• Wier LM, Elixhauser A, Pfuntner A, Au DH. Overview of hospitalizations among patients with COPD, 2008. The Healthcare Cost and Utilization Project. Available at: http://wwwhcup-usahrqgov/reports/statbriefs/sb106jsp [Last accessed 31 October 2014]
   Google Scholar
• Arunthari V, Bruinsma RS, Lee AS, Johnson MM. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction. Respir Care 2012;57:1242-7
   PubMed Web of Science ®Google Scholar
• Haynes JM. Randomized controlled trial of a breath-activated nebulizer in patients with exacerbation of COPD. Respir Care 2012;57:1385-90
   PubMed Web of Science ®Google Scholar
• McDonough K, Gonzalez S, Sunnongmuang S, Alum S. Therapeutic substitution of long acting beta agonist/corticosteroid metered dose inhalers aformoterol and budesonide via nebulization at a 210 bed urban hospital. American Society of Health-System Pharmacists 2012 Midyear Clinical Meeting, Las Vegas, NV
   Google Scholar
• Wild, D. Bright ideas for boosting savings-and patient care. Pharm Pract News. February 2014. Available at: http://www.pharmacypracticenews.com/ViewArticle aspx?d=Operations%2b%26%2bManagement&d_id=53&i=February+2014&i_id=1035&a_id=25850 [Last accessed 24 September 2014]
   Google Scholar
• US Food and Drug Administration. Protecting and Promoting Your Health. FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. February 25, 2015
   Google Scholar